New prospective open-label study on anidulafungin for invasive candidiasis in children
February 27 2019
Recommendations for using anidulafungin (Ecalta/Eraxis) to treat invasive candidiasis in children are largely extrapolated from trials in adults. Dr Roilides and colleagues have published data from a trial of 49 children reporting a global response rate of 71% and a drug-related adverse event rate of 37% (10% discontinued due to AEs).
Rapid detection of by qPCR in a wide range of clinical specimens: has culture had its day?
February 20 2019
An evaluation of a qPCR test for Coccidioides showed good sensitivity (74%) and specificity (100%), and produced results within 4 hours - outperforming fungal culture.
Using mobile phone reminders for medication
February 15 2019
Forgetting to take medication can be a major barrier to successful treatment; this problem is exacerbated when the treatment dosing is infrequent.
Candida africana in recurrent vulvovaginal candidiasis patients
February 08 2019
Recurrent vulvovaginal candidiasis (RVVC) is a condition which, though not linked to mortality, can cause complications and significant psychological, physical and monetary costs.
Fungal Infection Care Ghana’s CPA Awareness Seminar on World Aspergillosis Day
February 07 2019
On February 1st World Aspergillosis Day was marked around the world, with several events occurring. In Ghana, Fungal Infections Care (FIC) held a seminar to raise awareness of chronic pulmonary aspergillosis (CPA).